- Q3 revenue decreased to $27.7M versus $29.4M in prior-year period (9-month revenue down to $67.3M from $106.7M).
- Q3 net loss improved to $(41.0)M or $(0.64) EPS compared to $(80.8)M or $(1.45) EPS.
- Announced first Autonomous Lab sale to Novo Nordisk.
Why is $DNA moving today? · SEC 8-K archive
$DNA SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $DNA: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $DNA filing catalyst
Why did $DNA trigger an AI stock catalyst alert?
$DNA triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -3.5/10). Headline: Ginkgo Bioworks Q3: Revenue Down to $27.7M, Net Loss Narrows to $41.0M. Key points: - Q3 revenue decreased to $27.7M versus $29.4M in prior-year period (9-month revenue down to $67.3M from $106.7M). - Q3 net loss improved to $(41.0)M or $(0.64) EPS compared to $(80.8)M or $(1.45) EPS. - Announced first Autonomous Lab sale to Novo Nordisk.
How did $DNA stock react after the SEC filing?
After the SEC 8-K for $DNA, observed market reaction: T0 price $9.96. Past moves do not guarantee future results.
Where can I get real-time $DNA SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $DNA via Telegram and the VIP Web Terminal from €10/month.